Sljedeći

Auto Play

Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL

9 Pogledi • 08/09/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play